SB 201-1_ Filed 01/25/2012, 11:42 ChairPerson
The Senate Committee on Health and Provider Services, to which was referred Senate Bill No. 201, has
had the same under consideration and begs leave to report the same back to the Senate with the
recommendation that said bill be AMENDED as follows:
SOURCE: Page 1, line 1; (12)AM020101.1. -->
Page 1, between the enacting clause and line 1, begin a new
paragraph and insert:
SOURCE: IC 16-18-2-128.5; (12)AM020101.1. -->
"SECTION 1. IC 16-18-2-128.5, AS ADDED BY P.L.126-2005,
SECTION 3, IS AMENDED TO READ AS FOLLOWS [EFFECTIVE
JULY 1, 2012]: Sec. 128.5. (a) "Fetal stem cell" means any of the
following types of stem cells taken from a fetus that was either
miscarried or stillborn from any of the following sources:
(2) Umbilical cord.
(3) Amniotic fluid.
(4) Fetal tissue.
(b) The term does not include any cells that are taken as the result
of an abortion.
unless the cells are permissible for use under applicable
SOURCE: Page 2, line 12; (12)AM020101.2. -->
Page 2, line 12, delete "," and insert " (as defined in
Page 2, after line 13, begin a new paragraph and insert:
" (d) Any person who recklessly, knowingly, or intentionally uses
a human embryo created with an ovum provided to a qualified
third party under this section for purposes of embryonic stem cell
research commits unlawful use of an embryo, a Class C felony.
Renumber all SECTIONS consecutively.
(Reference is to SB 201 as introduced.)
and when so amended that said bill do pass .
Committee Vote: Yeas 7, Nays 0.
Senator Miller, Chairperson
AM 020101/DI 97 2012